Results 171 to 180 of about 341,161 (289)

Socioeconomic and Linguistic Factors in Paediatric Type 1 Diabetes: Exploring Glycemic Outcomes, Technology Use, and Residual Beta‐Cell Function in Migrant‐Background Populations

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9535-9542, October 2026.
ABSTRACT Aims To investigate associations between migrant status, socioeconomic factors (SES), and residual beta‐cell function and glycemic outcomes in paediatric type 1 diabetes. Methods Retrospective study of 208 children (median [IQR] age 11 [8–14] years; 119 Italian, 89 from migrant‐background families) with glucometric (HbA1c, TIR, TITR, TAR, CV),
Silvia Savastio, Andrea E. Scaramuzza, Erica Pozzi, Valeria Castorani, Eleonora Chiarle, Aurora Craici, Valentina Todescato, Claudio Cavalli, Ivana Rabbone   +8 more
wiley   +1 more source

Autoimmune Pancreatitis, Diabetic Ketoacidosis, and Severe Hypertriglyceridemia: Unraveling a Pathophysiological Triad. [PDF]

Cureus
Vinga Akoubou D, Chaari I, Keita CO, Abessolo A, Idrissi A, Meftah A, El Jadi H.   +6 more
europepmc   +1 more source

Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9633-9643, October 2026.
ABSTRACT Aims Evidence regarding the efficacy and safety of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in monogenic diabetes is limited. We evaluated real‐world metabolic, renal, and safety outcomes of SGLT2i therapy in adults with monogenic diabetes.
Estelle Audrain, Pierre Bel Lassen, Christine Bellanné‐Chantelot, Marie Christine Vantyghem, Hippolyte Dupuis, Tiphaine Vidal‐Trecan, Nicolas Chevalier, Danièle Dubois‐Laforgue, Sophie Lamothe, Camille Vatier, Orianne Villard, René Valéro, Claire Briet, Corinne Vigouroux, Cécile Ciangura, Chloé Amouyal   +15 more
wiley   +1 more source

Leukocytosis in Diabetic Ketoacidosis Without Infection: A Diagnostic Challenge. [PDF]

Cureus
Ali K, Chandrasekara N, Cheng MW, Chandrasekara H.   +3 more
europepmc   +1 more source

Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Effective treatment options remain limited for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), including patients who have progressed after platinum‐based chemotherapy and systemic‐therapy‐naïve patients.
Jinguan Lin, Song Qu, Kunyu Yang, Tao Zhang, Yuansong Bai, Jian Wu, Yanjing Huang, Meiyu Fang, Xianling Liu, Xiaoming Huang, Nianyong Chen, Zhendong Li, Weidong Li, Songnan Zhang, Shurong Zhang, Guangyuan Hu, Yan Sun, Xiaohong Chen, Yanyan Liu, Shanghua Jing, Liangfang Shen, Zhiwei Chang, Liangzhi Xie, Wenlin Gai, Yan Wang, Xinyue Chen, Dongfang Liu, Ye Guo   +27 more
wiley   +1 more source

Discharge Remote Monitoring Systems for Glycemic Management After Hospital Discharge

Chronic Diseases and Translational Medicine, Volume 12, Issue 3, Page 253-259, September 2026.
Heat map of median number of telehealth interactions by subgroup and theme. Major themes identified included intervention after remote monitoring alerts (e.g., “Team reached out to participant and instructed participant to treat hypo.”), insulin dose adjustments (e.g., “Participant reported that prednisone dose is increasing … Called to discuss insulin
Nirali Shah, Camilla Levister, Riana Jumamil, Carol Levy, Margaret Crawford, Christian Hicks, Selassie Ogyaadu, Aslihan Ipek, Abigail Tamru, Madeleine Rouviere, Leah Kaplan, Ying Xu, Harsimran Singh, Daniel Cherñavvsky, Grenye O'Malley   +14 more
wiley   +1 more source

Prospective Evaluation of Quality‐of‐Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION‐HF 12‐Month Results

Clinical Cardiology, Volume 49, Issue 9, September 2026.
Among patients with HFrEF, initiation of dapagliflozin resulted in significant improvements in quality of life, as demonstrated by increased KCCQ‐23 scores during follow‐up. ABSTRACT Introduction Heart failure with reduced ejection fraction (HFrEF), defined by a left ventricular ejection fraction ≤ 40%, remains a major global health challenge ...
Victoria Potoupni, Aristi Boulmpou, Spyridon Maragkoudakis, Alexandros Briasoulis, Emmanouil Foukarakis, Alexia Stavrati, Konstantinos Papadopoulos, Katerina K. Naka, Anna Kotsia, Ioannis Parissis, Antonios Ziakas, Stamatis Adamopoulos, Dimitrios Tziakas, Sotirios Patsilinakos, Melanie Konstantinidou, Periklis Davlouros, Zacharias Christogiannis, Konstantinos Tsitlakidis, Ioannis Pantelakis, Georgios Stefanakis, Marios Kolios, Ioannis Baltogiannis, Evangelos Voltyrakis, Christos Varounis, Andreas Samothrakitis, Dimitrios Krikidis, Panagiotis Tsialoukis, Zoe Paparepa, Dimitrios Gourlis, Nikolaos Papoutsidakis, Apostolos Karavidas, Christodoulos Papadopoulos   +31 more
wiley   +1 more source

Unmasking delayed recovery in severe diabetic ketoacidosis: clinical and biochemical clues from early resuscitation. [PDF]

Ann Pediatr Endocrinol Metab
Chung J, Kim B, Cheon CK, Kang JE, Kim Y, Yoo S.   +5 more
europepmc   +1 more source

Type 5 Diabetes Mellitus: Pathophysiology, Clinical Phenotype, and Nutritional Management

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 6, September 2026.
ABSTRACT Type 5 Diabetes Mellitus (T5DM) is an emerging diabetes phenotype linked to chronic undernutrition. It predominantly affects young, lean individuals in low‐ and middle‐income countries. After its formal recognition by the International Diabetes Federation in 2025, T5DM resurfaced as a clinically relevant insulin‐deficient phenotype.
İrem Nur Şahin Anılgan, Aslıhan Atar‐Uğurlu   +1 more
wiley   +1 more source

Hypophosphatemia in Diabetic Ketoacidosis During Intensive Care Admission. [PDF]

Med Sci (Basel)
Sieben NA, Blank S, Tabah A, White KC, Laupland KB, Edwards F, Attokaran A, Luke S, Kumar A, Whebell S, Parmar D, McCullough J, Garrett P, Ramanan M.   +13 more
europepmc   +1 more source